Circadian rest-activity rhythm as an objective biomarker of patient-reported outcomes in patients with advanced cancer

被引:49
作者
Innominato, Pasquale F. [1 ,2 ,3 ]
Komarzynski, Sandra [2 ,3 ]
Palesh, Oxana G. [4 ,5 ]
Dallmann, Robert [2 ]
Bjarnason, Georg A. [6 ]
Giacchetti, Sylvie [3 ,7 ]
Ulusakarya, Ayhan [3 ,8 ]
Bouchahda, Mohamed [3 ,8 ,9 ]
Haydar, Mazen [8 ]
Ballesta, Annabelle [2 ,3 ,10 ]
Karaboue, Abdoulaye [11 ]
Wreglesworth, Nicholas I. [1 ]
Spiegel, David [4 ,5 ]
Levi, Francis A. [2 ,3 ,8 ]
机构
[1] Betsi Cadwaladr Univ, Hlth Board, North Wales Canc Ctr, Bangor, Gwynedd, Wales
[2] Warwick Med Sch, Canc Res Ctr, Canc Chronotherapy Team, Coventry, W Midlands, England
[3] INSERM, Unit 935, French Natl Inst Hlth & Med Res, Villejuif, France
[4] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA
[5] Stanford Sch Med, Stanford Canc Inst, Stanford, CA USA
[6] Univ Toronto, Sunnybrook Odette Canc Ctr, Toronto, ON, Canada
[7] St Louis Hosp, Publ Hosp Paris, AP HP, Dept Oncol, Paris, France
[8] Hop Paul Brousse, Publ Hosp Paris, AP HP, Chronotherapy Unit,Dept Med Oncol, Villejuif, France
[9] Mousseau Clin, Evry, France
[10] Univ Warwick, Warwick Math Inst, Coventry, W Midlands, England
[11] AK Sci, Res & Therapeut Innovat, Vitry Sur Seine, France
基金
英国医学研究理事会; 欧盟第七框架计划;
关键词
actigraphy; Circadian; patient-reported outcome; quality of life; symptom; QUALITY-OF-LIFE; BREAST-CANCER; COLORECTAL-CANCER; SLEEP; FATIGUE; ACTIGRAPHY; DEPRESSION; SURVIVAL; TRIALS; DISRUPTION;
D O I
10.1002/cam4.1711
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Psychosocial symptoms often cluster together, arc refractory to treatment, and impair health-related quality of life (HR-QoL) in cancer patients. The contribution of circadian rhythm alterations to systemic symptoms has been overlooked in cancer, despite a causal link shown under jet lag and shift work conditions. We investigated whether the circadian rest-activity rhythm provides a reliable and objective estimate of the most frequent patient-reported outcome measures (PROMs). Methods: Two datasets were used, each involving concomitant 3-day time series of wrist actigraphy and HR-QoL questionnaires: EORTC QLQ-C30 was completed once by 237 patients with metastatic colorectal cancer; MD Anderson Symptom Inventory (MDASI) was completed daily by 31 patients with advanced cancer on continuous actigraphy monitoring, providing 1015 paired data points. Circadian function was assessed using the clinically validated dichotomy index I < O. Nonparametric tests compared PROMs and I < O. Effect sizes were computed. Sensitivity subgroup and temporal dynamics analyses were also performed. Results: I < O values were significantly lower with increasing symptom severity and worsening HR-QoL domains. Fatigue and anorexia were worse in patients with circadian disruption. The differences were both statistically and clinically significant (P < 0.001; d >= 0.33). Physical and social functioning, and global quality/enjoyment of life were significantly better in patients with robust circadian rhythm (P < 0.001; d >= 0.26). Sensitivity analyses validated these findings. Conclusion: Objectively determined circadian disruption was consistently and robustly associated with clinically meaningfully severe fatigue, anorexia, and interference with physical and social functioning. This supports an important role of the circadian system in the determination of cancer patients' HR-QoL and symptoms that deserves therapeutic exploitation.
引用
收藏
页码:4396 / 4405
页数:10
相关论文
共 59 条
[1]   THE EUROPEAN-ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER QLQ-C30 - A QUALITY-OF-LIFE INSTRUMENT FOR USE IN INTERNATIONAL CLINICAL-TRIALS IN ONCOLOGY [J].
AARONSON, NK ;
AHMEDZAI, S ;
BERGMAN, B ;
BULLINGER, M ;
CULL, A ;
DUEZ, NJ ;
FILIBERTI, A ;
FLECHTNER, H ;
FLEISHMAN, SB ;
DEHAES, JCJM ;
KAASA, S ;
KLEE, M ;
OSOBA, D ;
RAZAVI, D ;
ROFE, PB ;
SCHRAUB, S ;
SNEEUW, K ;
SULLIVAN, M ;
TAKEDA, F .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (05) :365-376
[2]   The role of actigraphy in the study of sleep and circadian rhythms [J].
Ancoli-Israel, S ;
Cole, R ;
Alessi, C ;
Chambers, M ;
Moorcroft, W ;
Pollak, CP .
SLEEP, 2003, 26 (03) :342-392
[3]   Sleep, fatigue, depression, and circadian activity rhythms in women with breast cancer before and after treatment: a 1-year longitudinal study [J].
Ancoli-Israel, Sonia ;
Liu, Lianqi ;
Rissling, Michelle ;
Natarajan, Loki ;
Neikrug, Ariel B. ;
Palmer, Barton W. ;
Mills, Paul J. ;
Parker, Barbara A. ;
Sadler, Georgia Robins ;
Maglione, Jeanne .
SUPPORTIVE CARE IN CANCER, 2014, 22 (09) :2535-2545
[4]   Net Clinical Benefit Analysis of Radiation Therapy Oncology Group 0525: A Phase III Trial Comparing Conventional Adjuvant Temozolomide With Dose-Intensive Temozolomide in Patients With Newly Diagnosed Glioblastoma [J].
Armstrong, Terri S. ;
Wefel, Jeffrey S. ;
Wang, Meihua ;
Gilbert, Mark R. ;
Won, Minhee ;
Bottomley, Andrew ;
Mendoza, Tito R. ;
Coens, Corneel ;
Werner-Wasik, Maria ;
Brachman, David G. ;
Choucair, Ali K. ;
Mehta, Minesh .
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (32) :4076-+
[5]   Systems Chronotherapeutics [J].
Ballesta, Annabelle ;
Innominato, Pasquale F. ;
Dallmann, Robert ;
Rand, David A. ;
Levi, Francis A. .
PHARMACOLOGICAL REVIEWS, 2017, 69 (02) :161-199
[6]   Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial [J].
Basch, Ethan ;
Deal, Allison M. ;
Kris, Mark G. ;
Scher, Howard I. ;
Hudis, Clifford A. ;
Sabbatini, Paul ;
Rogak, Lauren ;
Bennett, Antonia V. ;
Dueck, Amylou C. ;
Atkinson, Thomas M. ;
Chou, Joanne F. ;
Dulko, Dorothy ;
Sit, Laura ;
Barz, Allison ;
Novotny, Paul ;
Fruscione, Michael ;
Sloan, Jeff A. ;
Schrag, Deborah .
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (06) :557-+
[7]   Methodological challenges when using actigraphy in research [J].
Berger, Ann M. ;
Wielgus, Kimberly K. ;
Young-McCaughan, Stacey ;
Fischer, Patricia ;
Farr, Lynne ;
Lee, Kathryn A. .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2008, 36 (02) :191-199
[8]   Values of sleep/wake, activity/rest, circadian rhythms, and fatigue prior to adjuvant breast cancer chemotherapy [J].
Berger, Ann M. ;
Farr, Lynne A. ;
Kuhn, Brett R. ;
Fischer, Patricia ;
Agrawal, Sangeeta .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2007, 33 (04) :398-409
[9]   Patterns of circadian activity rhythms and their relationships with fatigue and anxiety/depression in women treated with breast cancer adjuvant chemotherapy [J].
Berger, Ann M. ;
Wielgus, Kimberly ;
Hertzog, Melody ;
Fischer, Patricia ;
Farr, Lynne .
SUPPORTIVE CARE IN CANCER, 2010, 18 (01) :105-114
[10]   Sleep and mortality: cause, consequence, or symptom? [J].
Cappuccio, Francesco P. ;
Miller, Michelle A. .
SLEEP MEDICINE, 2013, 14 (07) :587-588